TIL
$10.71
Revenue | $0Mn |
Net Profits | $-12.93Mn |
Net Profit Margins | -Inf% |
Instil Bio, Inc.’s revenue jumped NaN% since last year same period to $0Mn in the Q4 2023. On a quarterly growth basis, Instil Bio, Inc. has generated NaN% jump in its revenue since last 3-months.
Instil Bio, Inc.’s net profit jumped 76% since last year same period to $-12.93Mn in the Q4 2023. On a quarterly growth basis, Instil Bio, Inc. has generated 80.83% jump in its net profits since last 3-months.
Instil Bio, Inc.’s net profit margin jumped NaN% since last year same period to -Inf% in the Q4 2023. On a quarterly growth basis, Instil Bio, Inc. has generated NaN% jump in its net profit margins since last 3-months.
EPS Estimate Current Quarter | -2.23 |
EPS Estimate Current Year | -2.23 |
Instil Bio, Inc.’s earning per share (EPS) estimates for the current quarter stand at -2.23 - a 21.48% jump from last quarter’s estimates.
Instil Bio, Inc.’s earning per share (EPS) estimates for the current year stand at -2.23.
Earning Per Share (EPS) | -1.99 |
Instil Bio, Inc.’s earning per share (EPS) fell -729.17% since last year same period to -1.99 in the Q4 2023. This indicates that the Instil Bio, Inc. has generated -729.17% annual rate of fall in its earning per share (EPS) in the last 4 quarters.
Earnings Date | Estimated EPS | Reported EPS | Surprise % |
---|---|---|---|
2023-11-13 | -0.1 | -0.52 | -420% |
2024-03-21 | -2.84 | -1.99 | 29.93% |
2023-05-11 | -0.15 | -0.44 | -193.33% |
2023-08-14 | -0.16 | -0.14 | 12.5% |